James Bibb,
Associate Professor,
University of Texas Southwestern Medical Center
James Bibb is a recognized expert in neuronal signal transduction. His doctoral thesis research was conducted at State University of New York at Stony Brook. He received his postdoctoral training in the laboratory of Paul Greengard at the Rockefeller University and his work on dopamine neurotransmission was cited in the 2000 Nobel Prize in Physiology or Medicine. Dr. Bibb has over 70 publications, three patents, and is an Associate Professor at UT Southwestern. His research interests include cognition enhancement, neuronal injury including stroke and traumatic brain injury, depression, addiction, and schizophrenia. His lab’s research is funded by institutions and foundations including the National Institutes of Mental Health, Neurological Disorders and Stroke, and Drug Addiction, and the American Cancer Society. You can read more about his research at http://www4.utsouthwestern.edu/bibblab/.
The Convergence of Mechanistic Targets for Neurodegeneration and Cancer
Wednesday, 20 March 2013 at 14:15
Add to Calendar ▼2013-03-20 14:15:002013-03-20 15:15:00Europe/LondonThe Convergence of Mechanistic Targets for Neurodegeneration and CancerSELECTBIOenquiries@selectbiosciences.com
The molecular processes that mediate synaptic remodeling required for cognition and neuronal injury appear to share many mechanisms that in non-neuronal populations of cells can induce neoplasia. Evidence in the form of animal models and signal transduction pathways demonstrating this link and the validation of common mechanistic targets for drug discovery will be presented.
Add to Calendar ▼2013-03-19 00:00:002013-03-20 00:00:00Europe/LondonTargeting Protein-Protein InteractionsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2013-03-20 14:15:002013-03-20 15:15:00Europe/LondonThe Convergence of Mechanistic Targets for Neurodegeneration and CancerSELECTBIOenquiries@selectbiosciences.com
